P. Anborgh

发表

Phosphorylation-independent Regulation of Metabotropic Glutamate Receptor Signaling by G Protein-coupled Receptor Kinase 2*

P. H. Anborgh, S. Ferguson, R. Sterne‐Marr, 2002, The Journal of Biological Chemistry.

STRUCTURE-FUNCTION RELATIONSHIPS OF THE GTP-BINDING DOMAIN OF

E. Jacquet, P. H. Anborgh, M. Jensen, 1989 .

Structure-Function Relationships of The Gtp-Binding Domain of Elongation Factor Tu

E. Jacquet, P. H. Anborgh, A. Parmeggiani, 1989 .

Receptor/β-Arrestin Complex Formation and the Differential Trafficking and Resensitization ofβ 2-Adrenergic and Angiotensin II Type 1A Receptors

P. H. Anborgh, S. Ferguson, L. Dale, 2000 .

Plasma osteopontin as a biomarker of prostate cancer aggression: relationship to risk category and treatment response

C. Ménard, R. Bristow, C. Catton, 2012, British Journal of Cancer.

Inhibition of Metabotropic Glutamate Receptor Signaling by the Huntingtin-binding Protein Optineurin*

S. Cregan, R. Truant, P. H. Anborgh, 2005, Journal of Biological Chemistry.

Role of the metastasis-promoting protein osteopontin in the tumour microenvironment

A. Chambers, P. H. Anborgh, A. Tuck, 2010, Journal of cellular and molecular medicine.

β-Arrestins regulate a Ral-GDS–Ral effector pathway that mediates cytoskeletal reorganization

P. H. Anborgh, S. Ferguson, R. Feldman, 2002, Nature Cell Biology.

Rab5 Association with the Angiotensin II Type 1A Receptor Promotes Rab5 GTP Binding and Vesicular Fusion*

M. Caron, S. Laporte, P. H. Anborgh, 2002, The Journal of Biological Chemistry.

Ras-Specific Exchange Factor GRF: Oligomerization through Its Dbl Homology Domain and Calcium-Dependent Activation of Raf

D. Lowy, W. Vass, J. Declue, 1999, Molecular and Cellular Biology.

New antibiotic that acts specifically on the GTP‐bound form of elongation factor Tu.

P. H. Anborgh, A. Parmeggiani, P. H. Anborgh, 1991, The EMBO journal.

N Terminus of Sos1 Ras Exchange Factor: Critical Roles for the Dbl and Pleckstrin Homology Domains

D. Lowy, W. Vass, P. H. Anborgh, 1998, Molecular and Cellular Biology.

Site-directed mutagenesis of elongation factor Tu. The functional and structural role of residue Cys81.

J. Jonák, P. H. Anborgh, A. Parmeggiani, 1992, European journal of biochemistry.

Isoform-specific promotion of breast cancer tumorigenicity by TBX3 involves induction of angiogenesis

A. Chambers, J. Torchia, P. H. Anborgh, 2019, Laboratory Investigation.

beta 2-adrenergic receptor internalization, endosomal sorting, and plasma membrane recycling are regulated by rab GTPases.

P. H. Anborgh, S. Ferguson, J. L. Seachrist, 2000, The Journal of biological chemistry.

G Protein-coupled Receptor Kinase 2 Regulator of G Protein Signaling Homology Domain Binds to Both Metabotropic Glutamate Receptor 1a and Gαq to Attenuate Signaling*

P. H. Anborgh, S. Ferguson, R. Sterne‐Marr, 2004, Journal of Biological Chemistry.

Agonist-stimulated and tonic internalization of metabotropic glutamate receptor 1a in human embryonic kidney 293 cells: agonist-stimulated endocytosis is beta-arrestin1 isoform-specific.

P. H. Anborgh, S. Ferguson, M. Bhattacharya, 2001, Molecular pharmacology.

G Protein-coupled Receptor Kinase-mediated Desensitization of Metabotropic Glutamate Receptor 1A Protects against Cell Death*

S. Nakanishi, P. H. Anborgh, M. Bhatia, 2000, The Journal of Biological Chemistry.

Role of osteopontin as a predictive biomarker for anti-EGFR therapy in triple-negative breast cancer

A. Chambers, P. H. Anborgh, A. Tuck, 2018, Expert opinion on therapeutic targets.

Role of plasma osteopontin as a biomarker in locally advanced breast cancer.

L. Stitt, M. Brackstone, A. Chambers, 2015, American journal of translational research.

New dual monoclonal ELISA for measuring plasma osteopontin as a biomarker associated with survival in prostate cancer: clinical validation and comparison of multiple ELISAs.

L. Stitt, A. Chambers, M. Maeda, 2009, Clinical chemistry.

Ral and Phospholipase D2-Dependent Pathway for Constitutive Metabotropic Glutamate Receptor Endocytosis

P. H. Anborgh, S. Ferguson, A. Babwah, 2004, The Journal of Neuroscience.

Pre- and post-translational regulation of osteopontin in cancer

A. Chambers, P. H. Anborgh, A. Tuck, 2011, Journal of Cell Communication and Signaling.

Elongation factor Tu: a molecular switch in protein biosynthesis

A. Weijland, P. H. Anborgh, A. Parmeggiani, 1992, Molecular microbiology.

Antibiotic resistance mechanisms of mutant EF-Tu species in Escherichia coli.

L. Bosch, R. Hilgenfeld, L. Zeef, 1995, Biochemistry and cell biology = Biochimie et biologie cellulaire.

Elongation Factor Tu Mutants and Site-Directed Mutagenesis of tufA

K. Mortensen, J. Jonák, E. Jacquet, 1986 .

Enacyloxin IIa, an inhibitor of protein biosynthesis that acts on elongation factor Tu and the ribosome.

P. H. Anborgh, A. Parmeggiani, R. Cool, 1996, The EMBO journal.

Rapid and Direct Transport of Cell Surface APP to the Lysosome defines a novel selective pathway

S. Cregan, A. Lorenzen, Jonathan Samosh, 2010, Molecular Brain.

Cellular Trafficking of G Protein-coupled Receptor/β-Arrestin Endocytic Complexes*

M. Caron, J. Zhang, S. Laporte, 1999, The Journal of Biological Chemistry.